[go: up one dir, main page]

NO314230B1 - 6-O-substituerte ketolider med antibakteriell aktivitet - Google Patents

6-O-substituerte ketolider med antibakteriell aktivitet Download PDF

Info

Publication number
NO314230B1
NO314230B1 NO19991022A NO991022A NO314230B1 NO 314230 B1 NO314230 B1 NO 314230B1 NO 19991022 A NO19991022 A NO 19991022A NO 991022 A NO991022 A NO 991022A NO 314230 B1 NO314230 B1 NO 314230B1
Authority
NO
Norway
Prior art keywords
compound
formula
quinolyl
substituted
phenyl
Prior art date
Application number
NO19991022A
Other languages
English (en)
Norwegian (no)
Other versions
NO991022L (no
NO991022D0 (no
Inventor
Yat Sun Or
Zhenkun Ma
Richard F Clark
Daniel T Chu
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27107953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO314230(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/888,350 external-priority patent/US5866549A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO991022D0 publication Critical patent/NO991022D0/no
Publication of NO991022L publication Critical patent/NO991022L/no
Publication of NO314230B1 publication Critical patent/NO314230B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19991022A 1996-09-04 1999-03-02 6-O-substituerte ketolider med antibakteriell aktivitet NO314230B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70777696A 1996-09-04 1996-09-04
US08/888,350 US5866549A (en) 1996-09-04 1997-07-03 6-O-substituted ketolides having antibacterial activity
PCT/US1997/015506 WO1998009978A1 (en) 1996-09-04 1997-09-02 6-o-substituted ketolides having antibacterial activity

Publications (3)

Publication Number Publication Date
NO991022D0 NO991022D0 (no) 1999-03-02
NO991022L NO991022L (no) 1999-05-03
NO314230B1 true NO314230B1 (no) 2003-02-17

Family

ID=27107953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991022A NO314230B1 (no) 1996-09-04 1999-03-02 6-O-substituerte ketolider med antibakteriell aktivitet

Country Status (27)

Country Link
US (4) US6028181A (hu)
EP (5) EP0929563B1 (hu)
JP (1) JP4597274B2 (hu)
KR (5) KR100568455B1 (hu)
CN (4) CN100441591C (hu)
AT (5) ATE299508T1 (hu)
BG (1) BG63547B1 (hu)
BR (1) BR9711661A (hu)
CA (1) CA2263972C (hu)
CZ (1) CZ300106B6 (hu)
DE (5) DE69733439T2 (hu)
DK (5) DK1291351T3 (hu)
ES (5) ES2244716T3 (hu)
HR (5) HRP970473B1 (hu)
HU (1) HU230166B1 (hu)
ID (1) ID19406A (hu)
IL (1) IL128681A0 (hu)
NO (1) NO314230B1 (hu)
NZ (1) NZ334274A (hu)
PL (1) PL188173B1 (hu)
PT (5) PT1291352E (hu)
RO (1) RO121473B1 (hu)
RU (1) RU2192427C2 (hu)
SI (1) SI20023B (hu)
SK (5) SK285536B6 (hu)
TR (1) TR199901127T2 (hu)
WO (1) WO1998009978A1 (hu)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
PT952157E (pt) 1998-04-24 2003-11-28 Pfizer Prod Inc Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
SK5812001A3 (en) * 1998-11-03 2001-12-03 Pfizer Prod Inc Novel macrolide antibiotics
AU3517700A (en) * 1999-03-15 2000-10-04 Abbott Laboratories 6-o-substituted macrolides having antibacterial activity
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
EP1171446B1 (en) 1999-04-16 2006-09-20 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
PT1181300E (pt) * 1999-06-07 2004-02-27 Abbott Lab Derivados 6-o-carbamato de cetolido
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
AU2002316550A1 (en) * 2001-07-03 2003-01-21 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6673774B2 (en) * 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
CN1585775A (zh) 2001-12-05 2005-02-23 奥索-麦克尼尔药品公司 可用作抗菌药的红霉素的6-o-酰基酮内酯衍生物
US6831068B2 (en) * 2002-02-13 2004-12-14 Abbott Laboratories Macrolide antibacterial compounds
US20030162729A1 (en) * 2002-02-13 2003-08-28 Zhenkun Ma Macrolides with activity against methicillin-resistant staphylococcus aureus
EP1474431A2 (en) * 2002-02-13 2004-11-10 Abbott Laboratories Macrolide antibacterial compounds
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6825172B2 (en) 2002-05-31 2004-11-30 Janssen Pharmaceutica, Nv 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
JPWO2004078771A1 (ja) * 2003-03-07 2006-06-08 大正製薬株式会社 2−フルオロ−6−o−置換ケトライド誘導体
CA2801100A1 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Macrolides and processes for their preparation
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
US6790835B1 (en) * 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
EP1670808A1 (en) * 2003-09-12 2006-06-21 Chiron Corporation Antimicrobial derivatives
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
RU2397987C2 (ru) * 2004-07-28 2010-08-27 Рэнбакси Лабораториз Лимитед Кетолидные производные в качестве антибактериальных агентов
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
CA2572442A1 (fr) * 2004-07-30 2006-03-09 Palumed S.A. Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
WO2006065743A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Tetracylic bicyclolides
CN101120011A (zh) 2004-12-21 2008-02-06 辉瑞产品公司 大环内酯
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
EP1985620A4 (en) 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd 10a-azalide compound
CN101541331A (zh) 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
WO2009019868A1 (ja) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. 10a、12位架橋型10a-アザライド化合物
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
KR101223158B1 (ko) * 2007-09-17 2013-01-17 이난타 파마슈티칼스, 인코포레이티드 6,11-다리걸친 바이아릴 매크로라이드
AU2008316830B2 (en) * 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
RU2011153353A (ru) 2009-05-27 2013-07-10 Вокхардт Рисерч Сентер Кетолидные соединения, обладающие противомикробной активностью
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CN108570083A (zh) 2010-03-22 2018-09-25 森普拉制药公司 大环内脂的结晶形式及其用途
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2820451C (en) 2010-12-09 2017-12-12 Wockhardt Limited Ketolide compounds
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
US8993739B2 (en) 2011-03-22 2015-03-31 Wockhardt Ltd. Process for preparation of ketolide compounds
CN102766089A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙烯-1-卤代物及其制备方法
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
GB201217310D0 (en) 2012-09-27 2012-11-14 C10 Pharma As Compounds
CA2905975A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CN110234323A (zh) * 2016-10-04 2019-09-13 Ti生物制药有限公司 具有抗菌活性的酮内酯
EP3589327A4 (en) * 2017-03-03 2022-04-06 Synovo GmbH NOVEL ANTI-INFECTION AND ANTI-INFLAMMATORY COMPOUNDS
CN109942653B (zh) * 2019-02-27 2021-06-25 北京理工大学 一种红霉素衍生物及其制备方法
CA3163337A1 (en) * 2019-12-02 2021-06-10 AliquantumRx, Inc. Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin
CN113817008B (zh) * 2021-07-15 2023-05-23 湖州师范学院 新型琥珀酰基十六元大环内酯的制备方法及用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
KR930702369A (ko) * 1990-10-15 1993-09-08 우에노 아키라 에리쓰로마이신 또는 그의 유도체의 2'위치 수식 화합물
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5403923A (en) * 1990-11-28 1995-04-04 Taisho Pharmaceutical Co., Ltd. 6-0-methylerythromycin A derivatives
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
CA2093303C (en) * 1992-04-09 1998-11-24 Abraham Araya Aluminosilicates
DK0638585T3 (da) * 1992-04-22 1996-12-02 Taisho Pharmaceutical Co Ltd 5-O-desosaminylerythronolid-A-derivater
JP3259429B2 (ja) * 1992-04-22 2002-02-25 大正製薬株式会社 5−o−デソサミニルエリスロノライドa誘導体
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2738571B1 (fr) * 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
JP2000500133A (ja) * 1995-11-08 2000-01-11 アボツト・ラボラトリーズ 三環式エリスロマイシン誘導体
US6274715B1 (en) 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
WO1998018808A1 (fr) * 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromycine
US6171807B1 (en) * 1996-11-13 2001-01-09 Associates Of Cape Cod, Inc. Detection and quantitation of endotoxin by fluorescence polarization

Also Published As

Publication number Publication date
USRE39591E1 (en) 2007-04-24
EP1291352A1 (en) 2003-03-12
RU2192427C2 (ru) 2002-11-10
SK285535B6 (sk) 2007-03-01
EP1291351B1 (en) 2005-07-13
BG103292A (en) 1999-12-30
PL188173B1 (pl) 2004-12-31
KR100576988B1 (ko) 2006-05-10
NO991022L (no) 1999-05-03
ES2242813T3 (es) 2005-11-16
KR100523679B1 (ko) 2005-10-26
SI20023A (sl) 2000-02-29
DK1291353T3 (da) 2005-10-03
HRP970473A2 (en) 1998-08-31
PT1291352E (pt) 2005-09-30
SI20023B (en) 2001-02-28
EP1291353B1 (en) 2005-06-01
EP1291350A1 (en) 2003-03-12
ATE296831T1 (de) 2005-06-15
HRP20060276A2 (en) 2007-10-31
HUP9902869A2 (hu) 2000-02-28
EP1291353A1 (en) 2003-03-12
HRP20060278A2 (en) 2007-10-31
DK1291350T3 (da) 2005-09-26
EP1291350B1 (en) 2005-05-25
KR20050044816A (ko) 2005-05-12
HRP20060275B1 (hr) 2014-04-11
ATE296308T1 (de) 2005-06-15
KR20050044815A (ko) 2005-05-12
DE69733369T2 (de) 2006-01-26
DK1291352T3 (da) 2005-09-19
CN1273475C (zh) 2006-09-06
HRP20060277B1 (hr) 2014-04-11
AU729348B2 (en) 2001-02-01
ES2242983T3 (es) 2005-11-16
KR20000068435A (ko) 2000-11-25
PT1291350E (pt) 2005-09-30
KR20050043994A (ko) 2005-05-11
HU230166B1 (hu) 2015-09-28
CA2263972A1 (en) 1998-03-12
CN1237183A (zh) 1999-12-01
EP0929563B1 (en) 2005-06-01
SK285533B6 (sk) 2007-03-01
HRP20060276B1 (hr) 2014-04-25
JP2001500855A (ja) 2001-01-23
DE69733370D1 (de) 2005-06-30
CN1680420A (zh) 2005-10-12
ATE296307T1 (de) 2005-06-15
KR20050043993A (ko) 2005-05-11
DE69733422T2 (de) 2006-05-04
CZ68599A3 (cs) 1999-08-11
CN1680418A (zh) 2005-10-12
CN100460415C (zh) 2009-02-11
PT1291351E (pt) 2005-11-30
CN1680419A (zh) 2005-10-12
SK28699A3 (en) 2000-03-13
PL332009A1 (en) 1999-08-16
HRP20060278B1 (hr) 2014-04-11
SK285534B6 (sk) 2007-03-01
DE69733370T2 (de) 2006-02-02
ES2242812T3 (es) 2005-11-16
RO121473B1 (ro) 2007-06-29
DE69733723D1 (de) 2005-08-18
EP1291352B1 (en) 2005-05-25
CZ300106B6 (cs) 2009-02-11
US6147197A (en) 2000-11-14
US6075133A (en) 2000-06-13
WO1998009978A1 (en) 1998-03-12
HRP20060275A2 (en) 2007-10-31
AU4178097A (en) 1998-03-26
IL128681A0 (en) 2000-01-31
SK286181B6 (sk) 2008-04-07
DK1291351T3 (da) 2005-10-24
NO991022D0 (no) 1999-03-02
ID19406A (id) 1998-07-09
KR100568455B1 (ko) 2006-04-07
ATE296832T1 (de) 2005-06-15
JP4597274B2 (ja) 2010-12-15
DE69733439D1 (de) 2005-07-07
HRP970473B1 (en) 2007-02-28
ES2242811T3 (es) 2005-11-16
ES2244716T3 (es) 2005-12-16
KR100610043B1 (ko) 2006-08-08
EP1291351A1 (en) 2003-03-12
CA2263972C (en) 2008-01-29
US6028181A (en) 2000-02-22
DE69733422D1 (de) 2005-07-07
HUP9902869A3 (en) 2001-04-28
CN100441591C (zh) 2008-12-10
DE69733439T2 (de) 2006-05-04
SK285536B6 (sk) 2007-03-01
EP0929563A1 (en) 1999-07-21
DE69733723T2 (de) 2006-04-20
PT1291353E (pt) 2005-10-31
HRP20060277A2 (en) 2007-10-31
BG63547B1 (bg) 2002-04-30
ATE299508T1 (de) 2005-07-15
TR199901127T2 (xx) 1999-07-21
DE69733369D1 (de) 2005-06-30
BR9711661A (pt) 1999-08-24
PT929563E (pt) 2005-10-31
DK0929563T3 (da) 2005-10-03
HK1021537A1 (en) 2000-06-16
NZ334274A (en) 2001-02-23

Similar Documents

Publication Publication Date Title
NO314230B1 (no) 6-O-substituerte ketolider med antibakteriell aktivitet
JP5107303B2 (ja) 抗菌活性を有する6−o−置換ケトリド
AU729348C (en) 6-O-substituted ketolides having antibacterial activity
CA2564020C (en) 6-o-substituted ketolides having antibacterial activity

Legal Events

Date Code Title Description
MK1K Patent expired